1h
The Print on MSNHow Chinese biotech firm BGI grew to rival US giant Illumina & enter US-China tariff warChina has put Illumina on its ‘unreliable entity list’ after the US imposed sanctions on Beijing Genomics Institute, also a ...
Analysts said the move comes amid rising trade tensions with the U.S. and as Illumina faces stiff competition in China’s ...
After the National Institutes of Health (NIH) announced late Friday that it would be following a Trump administration ...
The U.S. tariffs on China include a broad 10% levy on imported goods. China’s response was more targeted, with 15% tariffs on ...
The Chinese government listed Illumina, whose global headquarters is in California, as an “unreliable entity” shortly after ...
Illumina's (ILMN) stock slid 5% post-market after it released its Q4 earnings report and reiterated its 2025 guidance, ...
The general mood among these heavyweight investors is divided, with 37% leaning bullish and 37% bearish. Among these notable options, 4 are puts, totaling $366,099, and 4 are calls, amounting to ...
The placement of Illumina in China's unreliable entity list could have disruptive implications. Read why I remain bullish on ...
For all of last year, Illumina’s net loss grew 5% from $1.161 billion to $1.223 billion, on revenue that fell 3% from $4.505 ...
Angle announces new results for dual analysis of CTC-DNA and ctDNA using Illumina assay and sequencing platform: London Saturday, February 1, 2025, 15:00 Hrs [IST] Angle plc, a wo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results